International journal of pharmaceuticsHumansGlaucomaNanotechnologyAnimalsIntraocular Pressure
Advancing glaucoma treatment with nanotechnology: a new frontier in ophthalmology.
Roghayyeh Baghban, Mohammad Reza Khalili, Athar Zareei, Mohammad Reza Talebnejad
Published: 202510.1016/j.ijpharm.2025.126210
Abstract
Glaucoma is defined by the progressive degeneration of retinal ganglion cells (RGCs), which ultimately results in permanent vision loss. Reducing Intraocular pressure (IOP) is now the primary therapeutic approach; however, it merely delays the diseas…
Preview only. Read the full abstract at the source